Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,779 public trials 700 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

NCT03543813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • University of Southern California Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 25 locations
View Trial Details
Completed

Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma

NCT03976102

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • American Oncology Partners of Maryland Bethesda, Maryland, United States
  • University of Tennessee Medical Center - Cancer Institute Knoxville, Tennessee, United States
  • Gulf coast Oncology Associates, PA Houston, Texas, United States
View Trial Details
Completed

My Choices: Efficacy and Implementation Study

NCT05358613

Conditions
Alcohol Drinking, Alcohol Use Disorder, Mild, Alcohol Use, Unspecified, +17 more
Locations
  • Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-Saint-Jean Jonquière, Quebec, Canada
  • Centre Intégré de Santé Services Sociaux de Laval Laval, Quebec, Canada
  • Centre intégré de Santé et de Services Sociaux de Chaudière-Appalaches Lévis, Quebec, Canada
  • Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale Québec, Canada
View Trial Details
Completed

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

NCT01606878

Conditions
Childhood Solid Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma

NCT03399513

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • HELIOS Hospital Berlin-Buch Berlin, Germany
  • Hospital Chemnitz Chemnitz, Germany
  • University Hospital Cologne Cologne, Germany
  • University Hospital Göttingen Göttingen, Germany
View Trial Details

Related conditions